News

Filters / Search

16 August 2022

Unitaid announces a US$45 million investment to increase access to lifesaving products that prevent and treat severe bleeding after childbirth

View More

04 August 2022

Unitaid landscape report identifies new technologies and innovative delivery strategies that hold promise for reducing vertical transmission of HIV, syphilis, hepatitis B, and Chagas

View More

01 August 2022

Partners announce reduced price for patient-friendly tuberculosis preventive treatments

View More

30 July 2022

Pooled data analysis from three large-scale clinical trials reveal long-term effects of dolutegravir-based treatment regimens on people living with HIV

View More

28 July 2022

AVAC, CIFF, MedAccess, Unitaid, and ViiV Healthcare announce collaboration to catalyse more affordable access to long-acting injectable cabotegravir for HIV prevention

View More

28 July 2022

A new agreement will allow for generic production of first and only long-acting injectable HIV prevention in 90 countries where majority of new HIV infections occur

View More

27 July 2022

World Hepatitis Day: Unitaid reaffirms its commitment to make hepatitis C elimination a reality by putting affected people at the heart of the response

View More

12 July 2022

Unitaid to incentivize generic production of life-saving medicine for people living with advanced HIV disease

View More

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.